Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: eFFECTOR Therapeutics, Inc. Q2 basic EPS USD -0.17

Aug 8 (Reuters) - eFFECTOR Therapeutics, Inc. Q2 operating income USD -7.855
million.
* Q2 operating expenses USD 7.855 million
* Q2 basic EPS USD -0.17
* Q2 net income USD -8.364 million

Recent news on Effector Therapeutics

See all news